Table 2.

Documentation of GDMT in patients with HFrEF

	Age, years		Gender		Hypertension		Diabetes		History of CAD
	<65 N=11,727	≥65 N=4,143	Men N=12,236	Women N=3,634	Yes N=5,879	No N=9,991	Yes N=3,675	No N=12,195	Yes N=4,329	No N=11,541
On ACE-I or ARB therapy	32.3%	36.9%	34.9%	28.6%	38.8%	30.4%	44.7%	30.1%	53.0%	26.2%
On Beta-blocker therapy	33.7%	38.3%	36.4%	29.9%	39.6%	32.2%	46.0%	31.6%	55.9%	27.0%
On ACE-I or ARB + Beta-blocker therapy	28.4%	32.9%	31.1%	24.4%	34.6%	26.6%	41.1%	26.1%	49.9%	22.0%

ACE-I = angiotensin converting enzyme inhibitor, ARB = angiotensin receptor blocker, CAD = coronary artery disease, GDMT = guideline-directed medical therapy, HFrEF = heart failure with reduced ejection fraction